Immutep Ltd.

08/30/2022 | Press release | Distributed by Public on 08/29/2022 18:00

Immutep Granted Japanese Patent for Eftilagimod Alpha, a Soluble Lag-3 Protein, in Combination with a PD-1 Pathway Inhibitor